Low import drug pricing may hamper entry of new drugs.

Due to unreasonable price policy on the imported drugs currently proceeded in the government a new drug especially in use of difficult diseases seems hardly to be introduced into Korean market. The government insurance price on imported drugs remains merely at 54% lower from the G7 countries, and therefore the introduction of new drugs and products from overseas will be blocked unless the gover...